Pardes Biosciences to Present at Jefferies Global Healthcare Conference
CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
News
Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer
Cambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) today announced…
Biomea Fusion to Present New Preclinical Data on BMF-219 in Two Diabetic Animal Models at ADA 2022
Company to host virtual investor R&D event on Monday, June 6, 2022 at 4:05 PM…
PLx Pharma Inc. to Present at JMP Securities 2022 Life Sciences Conference on June 15, 2022
SPARTA, N.J., June 01, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the…
Phathom Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference
FLORHAM PARK, N.J., June 01, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
Clearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in India
The patent was granted by India’s Office of the Controller-General of Patents, Designs and Trademarks…
Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting
PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platform MARLBOROUGH, Mass., June…
Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe Conference
BioXp™ system and RapidAMP™ cell-free DNA kit rapidly accelerate antibody discovery pipelines by addressing critical…
Cornerstone Pharmaceuticals to Present Pancreatic Cancer, Clear Cell Sarcoma and Biliary Tract Cancer Research Featuring CPI-613® (Devimistat) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Cranbury, NJ, June 01, 2022 (GLOBE NEWSWIRE) — Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”),…
Vor Bio to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell…
Ventyx Biosciences to Participate in the Jefferies Healthcare Conference
ENCINITAS, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a…
Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage
Lund, June 1, 2022 – Active Biotech (NASDAQ STOCKHOLM: ACTI) and its partner NeoTX announce…
AGTC Announces Age-Related Macular Degeneration Scientific Advisory Board
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
aTyr Pharma to Present at the 2022 Jefferies Healthcare Conference
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics…
Lexicon Pharmaceuticals to Participate in the Jefferies 2022 Healthcare Conference
THE WOODLANDS, Texas, June 01, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
CytomX Therapeutics to Present at Jefferies 2022 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 01, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Rubius Therapeutics to Present at the Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
Cue Biopharma to Present at the Jefferies Healthcare Conference
BOSTON, June 01, 2022 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
Aadi Bioscience to Present at the Jefferies Global Healthcare Conference
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical…
Dyve Biosciences to Participate in the BIO International Convention
CAMARILLO, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…